A polymer–lipid membrane artificial cell nanocarrier containing enzyme–oxygen biotherapeutic inhibits the growth of B16F10 melanoma in 3D culture and in a mouse model

References

• NCI National Cancer Institute. 2020. The cancer genome atlas (TCGA). Available from: https://www.cancer.gov/tcga.
   Google Scholar
• World Health Organization. 2020. Cancer mortality database. Available from: http://www-dep.iarc.fr/WHOdb/WHOdb.htm.
   Google Scholar
• Andersen R, Donia M, Ellebaek E, et al. Long-lasting complete responses in patients with metastatic melanoma after adoptive cell therapy with tumor-infiltrating lymphocytes and an attenuated IL2 regimen. Clin Cancer Res. 2016;22(15):3734–3745.
   PubMed Web of Science ®Google Scholar
• Wilson MA, Schuchter LM. Chemotherapy for melanoma. Cancer Treat Res. 2016;167:209–229.
   PubMedGoogle Scholar
• Editorial. The two directions of cancer nanomedicine. Nat Nanotechnol. 2019;14:1083.
   PubMed Web of Science ®Google Scholar
• Riley RS, June CH, Langer R, et al. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175–196.
   PubMed Web of Science ®Google Scholar
• Gershenwald JE, Scolyer RA, Hess KR, for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform, et al. Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–492.
   PubMed Web of Science ®Google Scholar
• Perego M, Maurer M, Wang JX, et al. A slow-cycling subpopulation of melanoma cells with highly invasive properties. Oncogene. 2018;37(3):302–312.
   PubMed Web of Science ®Google Scholar
• Du J, Su Y, Qian C, et al. Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells. Nat Commun. 2020;11(1):4830.
   PubMed Web of Science ®Google Scholar
• Meadows GG, Fu YM. 2005. Dietary restriction of specific amino acids modulates tumor and host interactions. In: Meadows GG, editor. Integration/interaction of oncologic growth. Cancer growth and progression, Vol. 15. Dordrecht: Springer. p. 271.
   Google Scholar
• Slominski A, Zmijewski MA, Pawelek J, et al. l-Tyrosine and l-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell Melanoma Res. 2012;25(1):14–27.
   PubMed Web of Science ®Google Scholar
• Chang TMS. Monograph on “ARTIFICIAL CELLS: biotechnology, nanotechnology, blood substitutes, regenerative medicine, bioencapsulation, cell/stem cell therapy”. Singapore: World Scientific Publisher/Imperial College Press; 2007. 435 pp. (Since April 2010 free online viewing http://www.medicine.mcgill.ca/artcell/2007ebookartcellweb.pdf).
   Google Scholar
• Chang TMS. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov. 2005;4(3):221–235.
   PubMed Web of Science ®Google Scholar
• Chang TMS. ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology. Artif Cells Nanomed Biotechnol. 2019;47(1):997–1013. https://www.tandfonline.com/doi/full/https://doi.org/10.1080/21691401.2019.1577885
   PubMed Web of Science ®Google Scholar
• Poon W, Kingston BR, Ouyang B, et al. A framework for designing delivery systems. Nat Nanotechnol. 2020;15(10):819–829.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chang TM. 2012. Nanobiotechnological nanocarriers containing polyhemoglobin-tyrosinase: effects on murine B16F10 melanoma cell proliferation and attachment. J Skin Cancer 2012: 673291. http://www.hindawi.com/journals/jsc/2012/673291/.
   Google Scholar
• Wang Y, Chang TMS. Biodegradable nanocarriers containing a nanobiotechnological complex for the in-vitro suppression of a melanoma cell line B16F10. J Nanosci: Curr Res. 2016;1:1–6. www.medicine.mcgill.ca/artcell/2016.pdf
   Google Scholar
• Zhang Q, Guo X, Cheng Y, et al. Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment. Sig Transduct Target Ther. 2020;5(1):58.
   PubMed Web of Science ®Google Scholar
• Chang TM. Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals. J Bioeng. 1976;1(1):25–32.
   PubMedGoogle Scholar
• Parveen S, Sahoo SK. Polymeric nanoparticles for cancer therapy. J Drug Target. 2008;16(2):108–123.
   PubMed Web of Science ®Google Scholar
• Guo C, Chang TMS. Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. Artif Cells Nanomed Biotechnol. 2018;46(7):1349–1363. http://www.artcell.mcgill.ca/safety_immune.pdf
   PubMed Web of Science ®Google Scholar